Medication info
Hawon Acyclovir 200 mg Tablet

Hawon Acyclovir 200 mg Tablet

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Hawon Pharmaceutical Co., Ltd.
Appearance
Pale blue round tablet
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 199702844 · Notified 1997.03.08 · Insurance code 651502120

Summary

Main use
Treatment and prevention of herpes simplex; treatment of chickenpox in children 2 years and older; treatment of shingles
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to begin administration as soon as possible after infection; in recurrent cases, administration should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) In patients with severe immunodeficiency or gastrointestinal absorption disorders, intravenous administration should be considered. 3) It is best to begin administration as soon as possible after infection; the earlier treatment is initiated, the better the effect. ○ Patients with renal impairment As patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, take care to extend the dosing interval or reduce the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration 2 times daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 1) Age 2 years and older: Same as the adult dosage. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective the sooner it is started after the chickenpox rash appears; administer within 24 hours of rash onset whenever possible.

Ingredients

Manufacturer
Hawon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex; treatment of chickenpox in children 2 years and older; treatment of shingles

  • Genital herpes
  • simplex herpes virus infections of skin and mucous membranes
  • herpes zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medicine is used to treat and prevent simplex herpes virus infections of the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in the treatment of herpes zoster virus infections, particularly in alleviating the pain that occurs during the acute phase. However, the effectiveness against postherpetic neuralgia has not yet been conclusively proven. It is used to treat chickenpox in children aged 2 years and older and generally improves various skin diseases caused by viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to begin administration as soon as possible after infection; in recurrent cases, administration should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) In patients with severe immunodeficiency or gastrointestinal absorption disorders, intravenous administration should be considered. 3) It is best to begin administration as soon as possible after infection; the earlier treatment is initiated, the better the effect. ○ Patients with renal impairment As patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, take care to extend the dosing interval or reduce the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration 2 times daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 1) Age 2 years and older: Same as the adult dosage. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective the sooner it is started after the chickenpox rash appears; administer within 24 hours of rash onset whenever possible.

Precautions

This medicine should not be used by individuals who are allergic to this medicine or its components. Care should be taken when using it in patients with impaired kidney function as central nervous system side effects may be more pronounced. Patients with impaired liver function should also be cautious due to the risk of worsening liver function. Special care should be taken when administering this medicine to children and the elderly. Serious allergic reactions such as shock, respiratory distress, and hypotension may occur, and treatment should be stopped immediately and medical attention sought if symptoms appear. If skin rash, fever, hives, or blisters appear, the medication should be discontinued, and medical advice should be sought. Serious dermatological abnormalities such as hair loss, severe dermatitis, and mucosal damage may also occur. Neurological symptoms such as changes in mental status, confusion, hallucinations, seizures, drowsiness, dizziness may occur, especially more frequently in the elderly and patients with reduced kidney function. Kidney function may deteriorate, so any signs of worsening kidney function should be reported to the healthcare provider. Blood-related abnormal symptoms may include bleeding, anemia, and changes in white blood cell counts. Liver function abnormalities or symptoms of jaundice may occur, so regular checks on liver health are necessary. Gastrointestinal symptoms may include nausea, vomiting, diarrhea, abdominal pain, and if these symptoms are severe, the medication should be discontinued. Overall symptoms such as fever, muscle weakness, headache may occur. Muscle pain or joint pain may also occur, so advise if there is any discomfort. Watch for irregular heartbeats, blood pressure changes, or chest pain. Symptoms of dysuria or urinary obstruction may occur. If symptoms do not improve within a certain period after starting treatment, alternative treatment methods should be considered, and early administration is effective. Patients with compromised immune function may require treatment in intravenous form. Adequate fluid intake is important during administration, especially during high-dose administration to prevent dehydration and kidney damage. In the case of recurrent genital herpes treatment, it should be discussed with a doctor whether to continue after long-term administration of more than one year. During the course of taking this medication, consciousness disturbances can occur, so it is advisable to avoid driving or operating dangerous machinery. As this medication can interact with other drugs, it is essential to inform the healthcare provider of any medications being taken. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of administration, and breastfeeding should be discontinued during treatment. Children should be administered the minimum dose only if necessary, and special caution must be taken with neonates or low birth weight infants. Elderly patients may experience increased drug concentrations due to decreased kidney function, so dosages and intervals should be adjusted, and adequate hydration should be provided. In cases of overdose, serious symptoms such as agitation, coma, and seizures may occur, requiring immediate medical attention, and blood dialysis may be needed. High-dose administration of this medication may cause genetic abnormalities, so the recommended dosage should be adhered to.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • respiratory distress
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 120 more
  • urticaria-like erythema
  • hives
  • alopecia
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • restlessness
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • abnormal sensations
  • ataxia
  • gait disturbances
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • neutropenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • indigestion
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • increased blood pressure
  • decreased blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • respiratory distress
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • increased serum potassium
  • decreased serum albumin
  • restlessness
  • coma
  • convulsions
  • somnolence
  • elevated BUN/Cr
  • renal failure
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • coma.

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to avoid exposure to air, and it is best to keep it at room temperature between 1 degree and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be well maintained and degradation can be prevented.

Appearance and packaging

Appearance

Pale blue round tablet

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.